Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials

Multiple myeloma (MM) is an incurable hematologic malignancy with disparities in outcomes noted among racial-ethnic subgroups, likely due to disparities in access to effective treatment modalities. Clinical trials can provide access to evidence-based medicine but representation of minorities on ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Ailawadhi, Sikander, Jacobus, Susanna, Sexton, Rachael, Stewart, Alexander K., Dispenzieri, Angela, Hussein, Mohamad A., Zonder, Jeffrey A., Crowley, John, Hoering, Antje, Barlogie, Bart, Orlowski, Robert Z., Rajkumar, S. Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035273/
https://www.ncbi.nlm.nih.gov/pubmed/29980678
http://dx.doi.org/10.1038/s41408-018-0102-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035273/
https://www.ncbi.nlm.nih.gov/pubmed/29980678
http://dx.doi.org/10.1038/s41408-018-0102-7

Ejemplares similares